Mankind Pharma543904Acquisition deal news
Mankind Pharma to acquire 70% of Belgium's Armed Cell Therapeutics via Dutch arm for EUR 48 million
By ScoutQuest · · 1 min read
70%Stake acquired in Armed Cell Therapeutics
- Stake Acquired
- 70% majority stake in Armed Cell Therapeutics B.V. (Belgium-incorporated)
- Cash Consideration
- EUR 48Mn to be invested in ACTx in installments for the 70% stake
- Subsidiary Investment
- up to EUR 45Mn in Mankind Pharma (Netherlands) B.V., aggregating to EUR 50Mn
- Target
- Armed Cell Therapeutics B.V. ("ACTx"), a Belgium-incorporated company; investment routed through Mankind Pharma (Netherlands) B.V.
- Transaction
- Acquisition of majority stake through wholly owned subsidiary
Mankind Pharma to acquire 70% of Belgium's Armed Cell Therapeutics via Dutch arm for EUR 48 million.
Mankind Netherlands incorporated
Board meeting
Also from Mankind Pharma
Mankind Pharma reschedules Q2 & H1 FY27 earnings conference call to 05:00 P.M. IST on October 26, 2026
22 Oct 2026
Mankind Pharma schedules in-person group Analyst / Institutional Investors' Meet on October 27, 2026 in Mumbai
22 Oct 2026
Mankind Pharma reschedules Q2 & H1 FY27 earnings conference call to 5:00 P.M. IST on October 26, 2026
22 Oct 2026
More numbers
- Investment in ACTx for 70% stakeEUR 48 million
- Stake acquired in Armed Cell Therapeutics70%
- Additional investment in Mankind Pharma (Netherlands) B.V.EUR 45Mn
- Aggregate investment limit in Mankind NetherlandsEUR 50Mn
- Previously approved investment limit in Mankind NetherlandsEUR 5Mn
- Authorised share capital of Mankind Pharma (Netherlands) B.V.EUR 50Mn
- ConsiderationEUR 48 million
Source: BSE · 15 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.